Good morning — here's the regulatory picture for alcohol and hemp/THC beverages, readable in about three minutes. Every headline links to the original source. A moderate news day: hemp-market economics lead, with the alcohol side quiet overnight. Top Story Report: December 11 federal hemp ban would close 68% of U.S. hemp businesses FEDERAL • Washington Examiner • Sep 8 A new Whitney Economics analysis projects that 68.1% of U.S. hemp-related businesses would shut down if the federal hemp ban takes effect December 11 as scheduled, and that states would lose $1.2–$1.5 billion in annual tax revenue. Positions on the deadline remain split: Sen. Tim Sheehy (R-MT) said this week that "a blanket hemp ban would wipe out American farm families, small businesses, and countless jobs," while the American Trade Association for Cannabis and Hemp's Chris Lindsey has urged Congress to let the ban take effect, saying the current framework "empowers bad actors, threatens public health and undermines state regulations." Why it matters: The report puts hard numbers on what a December 11 shutdown would mean for the hemp beverage segment and its retail and distribution partners — and those figures will feature in the congressional debate over the four pending bills that would repeal, delay, or replace the ban. |
Federal GAO: cannabis businesses still face limited banking access, elevated fees FEDERAL • Marijuana Moment • Sep 8 A Government Accountability Office report requested by four Democratic senators found that about 1,000 banks and credit unions filed reports indicating they served cannabis businesses in 2024 — a small share of institutions nationwide — and that operators report account closures, months-long application processes, and elevated fees, in some cases exceeding $100,000 a year. GAO found "no indication" any bank has been penalized solely for serving state-legal marijuana businesses. Why it matters: Banking and payment friction raises operating costs across cannabis-adjacent segments — a factor for any beverage company weighing THC-market entry, and for retail partners handling those product lines. |
Around the States Ohio dispensary voluntarily closes as regulators investigate two serious health events OHIO • Cannabis Business Times • Sep 8 Vext Science closed its Herbal Wellness Center dispensary in Jackson, Ohio at the request of the state Division of Cannabis Control, which is investigating two serious adverse health events possibly linked to products bought at the store. The company quarantined certain product lines across its Ohio retail and manufacturing operations pending independent testing; CEO Eric Offenberger said the company is "not aware of any substantiated evidence" tying its products to the events, and noted all inventory had passed state-mandated lab testing. Why it matters: A single adverse-event report can idle a licensed retail location and freeze product lines statewide — a reminder of how quickly quarantine and recall exposure moves through regulated product channels. |
Colorado regulators questioned over months-long delays in product-safety warnings COLORADO • Marijuana Moment • Sep 8 A Denver Gazette/ProPublica investigation found Colorado's Marijuana Enforcement Division averaged more than seven months between initial product complaints and public warnings, with one contaminated-product case taking three years. An MED spokesperson said building cases "requires investigative resources, evidence gathering, and test results"; former Denver regulator Thuy Vu called the timelines "ridiculous." The reporting also flagged that Colorado, unlike 26 other regulated states, does not require independent lab sample collection. Why it matters: Scrutiny of this kind often precedes rule changes on testing, sampling, and mandatory recalls — compliance-cost items for anyone manufacturing or distributing regulated consumables in Colorado. |
On the Radar Dec. 11, 2026 — The federal hemp ban takes effect, capping total THC at 0.4 mg per container. A Bradley client alert notes FDA has still not published its covered-cannabinoid list (originally due February 10) or defined "container," and four pending bills range from full repeal (Mace) to a two-year delay, the Griffith HEMP Act's FDA framework, and the Wyden–Merkley legalization bill. Sep. 15 — California's Cannabis Advisory Committee meets, with federal rescheduling developments and payment-system issues in the licensed supply chain on the agenda. DEA rescheduling — The agency's review of moving marijuana to Schedule III remains pending; this week's GAO banking report and the CRS licensing analysis both note outcomes that turn on how and whether it concludes. |
Jeremy Barnes | Chief Financial Officer, New Realm Brewing Co. Prepared for New Realm's leadership team and valued partners. This brief is for general informational purposes only and is not legal advice; it is compiled with AI assistance from the linked sources — please confirm details at the link before acting on them. Buttons not working? Reply to this email with the word subscribe or unsubscribe. Requests are processed automatically each morning before send. Read online & browse the archive: compliance.newrealmbrewing.com • Listen & follow: Apple Podcasts • Spotify • Amazon Music • All apps |